elements
-live
Search elements, keywords, and sectors
🔎
Elements
Subjects
Papers
Communities
Lab
API & MCP
Pricing
Log in
Sign up
Home
/
Subjects
/
Clathrin
← Back to subjects
Current data, viewed at
Yearly
resolution.
Personal members see monthly resolution →
Keyword
keyword
Clathrin
RIS
0.001
(Research Intensity Score)
Papers
124
Top papers
Identification and analysis of microplastics in peritumoral and tumor tissues of colorectal cancer
2025 · 28 citations
<p>Size-dependent cellular uptake and localization profiles of silver nanoparticles</p>
2019 · 283 citations
Cellular Uptake of Upconversion Nanoparticles Based on Surface Polymer Coatings and Protein Corona
2024 · 24 citations
Prophylactic supplementation with biogenic selenium nanoparticles mitigated intestinal barrier oxidative damage through suppressing epithelial-immune crosstalk with gut-on-a-chip
2025 · 17 citations
Hepatic Zbtb18 (Zinc Finger and BTB Domain Containing 18) alleviates hepatic steatohepatitis via FXR (Farnesoid X Receptor)
2024 · 25 citations
Newest papers
Priming the Liver Endocytic Pathway to Accelerate Hepatobiliary Clearance of Nanoparticles
2026 · 4 citations
Manganese-Templated Nontrivial Structures for MRI and Therapy
2026 · 1 citations
Microstrain-engineered platinum nanoclathrins for fuel cells
2026 · 1 citations
Prostate‑specific membrane antigen: Molecular functions and emerging roles as a therapeutic target (Review)
2026 · 1 citations
Copper Nanoparticles Enable Multi-Compartment Cuproenzyme Metalation in Cellular Models of Copper Deficiency
2026
A sample from the 100 top papers behind Clathrin.
Create a free account to browse them all →
Clathrin's history
Research intensity over time
Explore Clathrin's full history
Hover any year for its value and switch resolutions with a free account. Personal adds monthly detail and the historical-intensity (HRI) line.
Create a free account
Already have an account?
Log in
to explore the data.
Close ✕
Clathrin's papers
Ordered by current research-activity contribution.
Loading…
Close ✕
Read full text ↗
Share
Share on X
Share on Facebook
Share on LinkedIn
Copy link